Barbara Lopez Kunz,
MS

Ms. Barbara Lopez Kunz is leading the transformation of DIA through developing and implementing a strategy that focuses on driving thought leadership and innovation in development of therapeutics to improve the health of people worldwide. She is responsible for the leadership and oversight of DIA global operations and is accountable to the DIA Board of Directors. Ms. Lopez Kunz has held executive positions in both for-profit and non-profit organizations. Prior to joining DIA, she served as President of Health and Life Sciences at Battelle, one of the world’s largest, most respected research and development organizations, delivering $6.5 billion of research and development across more than 100 global locations. She has also served as Senior Vice President/General Manager for Thermo Fisher Scientific’s Biosciences Business, and guided the growth of ICI/Uniqema’s Latin America regional business during one of the most volatile periods in the region’s history, by establishing regional entities to take advantage of local trading opportunities, greatly improving cost effectiveness throughout the region.

Ms. Lopez Kunz holds 14 patents and started her career as a scientist. She has held various Board positions at Ohio State University Wexner Medical Center, BioOhio, International Scientific Standards (a joint venture in South Korea that enables the delivery of medical products to patients), and medical device companies Levitronix and POCARED. She has actively supported children’s health, serving on the inaugural board of the Childhood League School, which addresses the needs of developmentally challenged children in central Ohio, and as a director for Nationwide Children’s Hospital Research Institute and Children’s National Research Institute.

Ms. Lopez Kunz earned her MS in Polymer Science from the University of Akron and is certified in INSEAD’s International Executive program.